GSTM1 and COVID-19: The heme-iron dysregulation has been observed in COVID-19 [7], with binding signatures including hyperferritinemia, low hemoglobin (Hb) levels, low serum iron, anisocytosis, increased variation of red blood cell distribution width (RDW), and hypoxemia [8,9,10].